Goldline Pharmaceutical Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | 76.99x | 1,272,000 | 97,929,000 | ₹5 Cr |
| NII (HNI) | 🔥 1664.45x | 390,000 | 649,134,000 | ₹2 Cr |
| Retail | 🔥 874.20x | 900,000 | 786,780,000 | ₹4 Cr |
| Market Maker | — | 138,000 | — | ₹1 Cr |
| Σ Total | 🔥 598.69x | 2,562,000 | 1,533,843,000 | ₹11 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹129,000 |
| Retail (Max) | 13 | 39,000 | ₹1,677,000 |
| S-HNI (Min) | 14 | 42,000 | ₹1,806,000 |
| B-HNI (Min) | 67 | 201,000 | ₹8,643,000 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 28 | 24 | 20 |
| EBITDA | 6 | 4 | 2 |
| Profit After Tax | 3 | 2 | 0 |
| Net Worth | 10 | 8 | 6 |
| Total Assets | 26 | 23 | 19 |
| Reserves & Surplus | 2 | 4 | 2 |
| Total Borrowing | 11 | 11 | 11 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company – 8.90
- General corporate purposes –
Company Overview
Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Its product range is divided into five segments:
- Goldline Pharma: This category includes 42 products to cater to specialties like Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology.
- Goldline Cardinal: This category offers 54 products tailored for the Specialty division, serving medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians.
- Goldline Aayushman: This category comprises 18 products designed for the Specialty division, catering to medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners.
- Goldline InLife: This category includes 22 products tailored for the Specialty division, serving Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians.
- Goldline Wellness: This category includes 10 products tailored Supportive care plays a crucial role in cancer therapy.
The company do not manufacture products, it partner with third-party manufacturers who produce the medicines based on its market research and product specifications, ensuring quality and compliance with regulations.
All products are marketed and sold under the Goldline brand through our network of distributors, who supply to retailers and wholesalers. The company currently works with 15 manufacturers and 7 distributors, and it also support hospitals and healthcare providers with procurement and material supply.
The company sells products across the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Competitive Strengths:
- Experienced Promoters and Management Team with Industry Knowledge and a Track Record
- Asset-light Business Model and Competitive Products
- Scalable Business Model
- Wide and Diverse Range of Product Offerings
- Strong Supplier and Vendor Relationships
- Established Distribution Network